Effects of clofibrate in primary biliary cirrhosis hypercholesterolemia and gallstones

Gastroenterology. 1975 Oct;69(4):998-1000.

Abstract

A patient with primary biliary cirrhosis is reported in whom the administration of clofibrate in a dose of 1 g per day for 2 months resulted in a marked increase in hypercholesterolemia, and endoscopic retrograde cholangiography showed multiple intrahepatic gallstones. The stones disappeared 3 months after stopping clofibrate and starting chenodeoxycholic acid in a dose of 125 mg daily. These observations are discussed in relation to the known effects of clofibrate on bile composition.

Publication types

  • Case Reports

MeSH terms

  • Chenodeoxycholic Acid / therapeutic use
  • Cholelithiasis / chemically induced*
  • Cholelithiasis / drug therapy
  • Clofibrate / adverse effects*
  • Female
  • Humans
  • Hypercholesterolemia / chemically induced*
  • Liver Cirrhosis / drug therapy*
  • Middle Aged
  • Remission, Spontaneous

Substances

  • Chenodeoxycholic Acid
  • Clofibrate